Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma

Summary

The purpose of this study is to evaluate the efficacy and safety of dose reduced postoperative radiotherapy combined with Anlotinib for patients of soft tissue sarcoma

Timeline

Start

2022-11

Primary completion

2023-01

Completion

2024-05

Drugs

Indications